News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immune Design Corporation Appoints Jan Henrik ter Meulen, M.D., Chief Scientific Officer


10/1/2013 9:39:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SEATTLE and SAN FRANCISCO, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the appointment of Jan Henrik ter Meulen, M.D., Dr. habil., DTM&H, as its Chief Scientific Officer.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES